Publication: A prophylactic approach for bone marrow transplantation from a hepatitis B surface antigen-positive donor
Issued Date
2007-02-21
Resource Type
ISSN
10079327
Other identifier(s)
2-s2.0-34047102950
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
World Journal of Gastroenterology. Vol.13, No.7 (2007), 1138-1140
Suggested Citation
Abhasnee Sobhonslidsuk, Artit Ungkanont A prophylactic approach for bone marrow transplantation from a hepatitis B surface antigen-positive donor. World Journal of Gastroenterology. Vol.13, No.7 (2007), 1138-1140. doi:10.3748/wjg.v13.i7.1138 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/24985
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
A prophylactic approach for bone marrow transplantation from a hepatitis B surface antigen-positive donor
Author(s)
Other Contributor(s)
Abstract
It has been accepted that bone marrow transplantation (BMT) is the only curative therapeutic option for certain hematologic malignancies. The southeast Asia region is an endemic area of hepatitis B virus (HBV) infection; thus, BMT using a hepatitis B surface antigen (HBsAg)-positive donor is occasionally unavoidable. Organ transplantation using a HBsAg-positive donor can lead to post-transplantation de novo HBV infection and severe HBV-related hepatitis if no effective prophylactic measures are taken prior to and after transplantation. In this report, a four-level approach was designed for a patient with chronic myeloid leukemia, beginning with a booster HBV vaccination before performing BMT with a HBsAg-positive donor. Prior to BMT, the HBV viral load of the donor was reduced to an undetectable level by antiviral therapy. After BMT, hepatitis B immunoglobulin was administered intramuscularly for 1 wk together with a long-term antiviral drug, lamivudine. One year after discontinuation of lamivudine, the patient is still free of HBV infection. © 2007 The WJG Press. All rights reserved.